1995;16:1825 32. 622. Goyal A, Alexander JH, Hafley GE, et al. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery. Ann Thorac Surg. 2007;83:993 1001. 623. Sjoland H, Caidahl K, Lurje L, et al. Metoprolol treatment for two years after coronary bypass grafting: effects on exercise capacity and signs of myocardial ischaemia. Br Heart J. 1995;74:235 41. 624. Chen J, Radford MJ, Wang Y, et al. Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction? Arch Intern Med. 2000;160:947 52. 625. Chan AY, McAlister FA, Norris CM, et al. Effect of beta-blocker use on outcomes after discharge in patients who underwent cardiac surgery. J Thorac Cardiovasc Surg. 2010;140:182 7. 626. Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foun- dation. Circulation. 2011: published online before print November 3, 2011, 10.1161/CIR.0b013e318235eb4d. Accessed November 3, 2011. 627. Oosterga M, Voors AA, Pinto YM, et al. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia. Am J Cardiol. 2001;87:542 6. 627a.Collaborative Group on ACE Inhibitor Trials. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 1995;273:1450 6. 627b.The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. [published corrections appear in N Engl J Med. 2000;342:1376;2000;342:748]. N Engl J Med. 2000;342:145 53. 628. Fox KM, Bertrand ME, Remme WJ, et al. efficacy of perindopril in reducing risk of cardiac events in patients with revascularized coronary artery disease. 